American Journal of Psychiatry
- Volume 176
- Number 11
- November 2019
Editor’s Note
Editorials
Clinical Case Conference
Reviews and Overviews
Publication date: 01 November 2019
Pages904–910Psychiatry has been at the forefront of advancing clinical transcranial magnetic stimulation (TMS) since the mid-1990s, shortly after the invention of modern TMS in 1985 by Barker. Clinical TMS for psychiatric applications is advancing rapidly, with novel ...
https://doi.org/10.1176/appi.ajp.2019.19090957Articles
Publication date: 21 May 2019
Pages911–922Objective: Despite the staggering consequences of the opioid epidemic, limited nonopioid medication options have been developed to treat this medical and public health crisis. This study investigated the potential of cannabidiol (CBD), a nonintoxicating ...
https://doi.org/10.1176/appi.ajp.2019.18101191Publication date: 24 June 2019
Pages923–930Objective: Research has suggested that subanesthetic doses of ketamine may work to improve cocaine-related vulnerabilities and facilitate efforts at behavioral modification. The purpose of this trial was to test whether a single ketamine infusion improved ...
https://doi.org/10.1176/appi.ajp.2019.18101123Publication date: 21 May 2019
Pages931–938Objective: Obsessive-compulsive disorder (OCD) is a chronic and disabling condition that often responds unsatisfactorily to pharmacological and psychological treatments. Converging evidence suggests a dysfunction of the cortical-striatal-thalamic-cortical ...
https://doi.org/10.1176/appi.ajp.2019.18101180Publication date: 24 June 2019
Pages939–948Objective: Posttraumatic stress disorder (PTSD) is a highly prevalent psychiatric disorder associated with disruption in social and occupational function. Transcranial magnetic stimulation (TMS) represents a novel approach to PTSD, and intermittent theta-...
https://doi.org/10.1176/appi.ajp.2019.18101160Publication date: 04 October 2019
Pages949–956Objective: Deep brain stimulation of the subcallosal cingulate (SCC DBS) has been studied as a potential treatment for severe and refractory major depressive disorder since 2005. The authors used an open-label, long-term follow-up design to examine ...
https://doi.org/10.1176/appi.ajp.2019.18121427Publication date: 20 September 2019
Pages957–965Objective: The authors sought to determine whether targeted treatment of insomnia with controlled-release zolpidem (zolpidem-CR) in suicidal adults with insomnia would provide a reduction in suicidal ideation superior to placebo. Methods: Reducing Suicidal ...
https://doi.org/10.1176/appi.ajp.2019.19030267Letters to the Editor
Past Issues
View Issues Archive
Vol. 181 | No. 11
Vol. 181 | No. 10
Vol. 181 | No. 9
